tirzepatide and fibroids How the weight loss drug is also helping heart failure patients Promising Trial for a Drug

Research shows that people on semaglutide typically eat 60-70% less food than before starting the medication, which means every single bite has to count

Genetic Variants Linked to GLP1 Resistance Carried by 1 in 10 Individuals Researchers linked GLP1 resistance to genetic variants that disrupt the PAM enzyme

Careful and targeted patient selection are required, alongside robust education and novel technologies to monitor glucose and ketone levels to mitigate the risks and enhance the beneficial effects of SGLT2i and GLP-1 RA therapy

11 Alternatively, one could consider swapping rapid acting insulin for regular insulin due to the difference in pharmacokinetics that may be a benefit in the setting of delayed gastric emptying [see figure below]

& Ingelsson, E